688319 Chengdu Olymvax Biopharmaceuticals Inc
- 8.82
- -0.06-0.68%
Chengdu Olymvax Biopharmaceuticals Inc News
Announcement of Chengdu Olin Biotechnology Co., Ltd. on voluntary disclosure of the approval of Phase I clinical trial of oral recombinant Helicobacter pylori vaccine (E. coli) in Australia.
Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders of Chengdu Olin Biotechnology Co., Ltd.
Legal Opinions of Beijing Deheng (Chengdu) Law Firm on the 2023 Annual General Meeting of Shareholders of Chengdu Olin Biotechnology Co., Ltd.
Chengdu Olin Biotechnology Co., Ltd. 2023 Annual General Meeting of Shareholders Meeting Materials
Notice of Chengdu Olin Biotechnology Co., Ltd. on holding the 2023 Annual General Meeting of Shareholders
Chengdu Olin Biotechnology Co., Ltd. 2023 Internal Control Evaluation Report
Report on the performance of the Audit Committee of the Board of Directors of Chengdu Oulin Biotechnology Co., Ltd. 2023
Special Report of the Board of Directors of Chengdu Oulin Biotechnology Co., Ltd. on the independence of independent directors
Report on the audit committee of the board of directors of Chengdu Olin Biotechnology Co., Ltd. on the performance of supervisory duties by the accounting firm
Announcement of Chengdu Olin Biotechnology Co., Ltd. on changing the registered capital, amending the “Articles of Association”, and registering industrial and commercial changes
Announcement of Chengdu Olin Biotechnology Co., Ltd. on the repurchase and cancellation of the 2023 Restricted Stock Incentive Plan to grant capital reduction to some Class I restricted stocks for the first time and notice to creditors
Announcement of Chengdu Olin Biotechnology Co., Ltd. on preparations for asset impairment in 2023
Announcement of Chengdu Olin Biotechnology Co., Ltd. on requesting the company's shareholders' meeting to authorize the board of directors to issue shares to specific targets through simple procedures and handle related matters
Chengdu Olin Biotechnology Co., Ltd. 2024 “Improve Quality, Increase Efficiency and Value Return” Action Plan
Announcement of Chengdu Olin Biotechnology Co., Ltd. on holding a briefing on the results and cash dividends for the first quarter of 2023 and 2024
Announcement of Chengdu Olin Biotechnology Co., Ltd. on voluntary disclosure of withdrawal of drug registration applications
Announcement of Resolutions of the 2024 First Extraordinary General Meeting of Shareholders of Chengdu Olin Biotechnology Co., Ltd.
Legal Opinions of Beijing Deheng (Chengdu) Law Firm on the 2024 First Extraordinary General Meeting of Shareholders of Chengdu Olin Biotechnology Co., Ltd.
Chengdu Olin Biotechnology Co., Ltd. 2024 First Extraordinary General Meeting of Shareholders Meeting Data
Notice of Chengdu Olin Biotechnology Co., Ltd. on convening the first extraordinary general meeting of shareholders in 2024
Analysis
Price Target
No Data
